Primaries are underway to select candidates for the 2026 midterm elections, but many voters are looking ahead to who is running for president in 2028 and still questioning — if or how Donald Trump can ...

The refreshed Run menu is rolling out now to Windows testers in the Experimental Channel. The refreshed Run menu is rolling out now to Windows testers in the Experimental Channel. is a news writer who ...

SNC’s site for E-4C work in Dayton, Ohio, has rapidly grown since the company won the competition in 2024. Credit: SNC The future backbone of U.S. nuclear command and control is taking shape in a set ...

A Florida woman accused of fleeing a crash that killed an 8-year-old boy was seen shaking her head and laughing during her first court appearance Friday as a judge read the charges against her via ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Department of Homeland Security (DHS) said that it has restored the ...

Conan Exiles remains popular. When it first came out, everybody thought the novelty of being able to change the size of your manhood or your boobs was all that it had, but it turns out the genetalia ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

Amgen’s decision to terminate its rocatinlimab collaboration with Kyowa Kirin follows the publication of data on Sanofi’s rival OX40 drug candidate amlitelimab. (iStock / Getty Images Plus) Amgen has ...